Investor Type | Firm |
Industries | BioTech • A.I. (& Big Data) |
Investing | China |
Investment Range | $80,000,000 - $80,000,000 |
Oceanpine Healthcare Fund is a specialized healthcare venture firm with a strategic base in Beijing, China. They focus on injecting capital into innovative companies that are poised to transform the healthcare landscape. With an investment range of up to $80 million, they target high-growth potential sectors within the healthcare industry. Their investments span across a diverse array of segments including biotech, medical devices, innovative drug discovery, genome sequencing, and in-vitro diagnosis (IVD). Moreover, they are particularly attentive to firms that leverage artificial intelligence and big data to drive advancements in healthcare solutions. Oceanpine Healthcare Fund's mission is to support ventures that have the potential for significant clinical and commercial impact. They look for companies that embody scientific and technological excellence, with the drive to bring forth groundbreaking products and services. Their deep-rooted expertise in the healthcare field enables them to identify key opportunities and provides them with the ability to guide their portfolio companies towards achieving their objectives. Oceanpine Healthcare Fund has positioned itself to play a vital role in the healthcare innovation ecosystem by offering financial resources, strategic guidance, and access to a network of industry experts. By doing so, they aim to help entrepreneurs to not only navigate but also accelerate the complex process of bringing healthcare innovations to market.